Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03793699
Other study ID # 2017_55
Secondary ID 2017-A03649-44
Status Recruiting
Phase
First received
Last updated
Start date February 4, 2019
Est. completion date December 2022

Study information

Verified date September 2020
Source University Hospital, Lille
Contact Vincent JARDON, MD
Phone 320 44 45 84
Email vincent.jardon@chru-lille.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Several studies have demonstrated an association between sleep disorders such as insomnia and nightmares to suicidal ideations and behaviors.

Nevertheless, some of these studies are methodologically questionable especially in the exploration of sleep disorders. Furthermore, confounding factors such as depressive symptomatology are not controlled and the measurement of suicidal behavior has often been taken into account as a historical measure, not as a current event, which introduces uncertainties and a lack of precision regarding the temporality of the phenomena.

Today, while the links between sleep disorders and suicidal risk are well known, we have a lack of information on the importance and the role of sleep disorders as a precipitating factor. Indeed, few studies have evaluated the temporal link between sleep disorders and suicidal acts.

The objective of this study is to evaluate the links between acute and chronic sleep disorders and the risk of suicide attempt


Description:

Pilot, prospective, monocentric case-control study.

There are 2 groups of subjects :

- group of patients who have made a suicide attempt

- control group with only suicidal ideas

First visit V1 is performed within the first 72 hours of hospitalization. A re-assessment is scheduled 1 month after (V2).

At V1, collected parameters are : chronic sleep disorders, chronotype, specific sleep disorders in posttraumatic stress disorder, nightmares and the distress associated, childhood trauma, cognitive dysfunction, suicidal ideation and psychopathologic assessment.

At V2, we assess evolution of sleep disturbances and suicidal ideation.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 2022
Est. primary completion date December 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria

Criterion specific to the studying group :

- Subjects hospitalized and whose indication of hospitalization is a suicide attempt by voluntary drug intoxication or phlebotomy during the last 72 hours, without any history of attempted suicide

Criterion specific to the control group:

- Subjects hospitalized since less than 72 hours, and whose indication of hospitalization is the presence of suicidal ideas, without any history of attempted suicide

Exclusion Criteria:

- Pregnant of lactating women

- Diagnosed dementia pathology

- Proven intellectual disability

- Patient whose physical or mental state does not allow the passing of the tests of the study

- Under protective measures (guardianship/supervision)

- Refusal to participate in the study

- Diagnosed with chronic or severe psychiatric illness (psychotic disorder, bipolarity)

Study Design


Locations

Country Name City State
France Hôpital Fontan, CHU Lille

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sleep disorders intensity by the Insomnia Severity Index (ISI) ISI score in the last 2 weeks between a group of suicide attempts and a group with suicidal thoughts suicidal The Insomnia Severity Index has seven questions. The seven answers are added up to get a total score. at the 48 hours after the hospitalization; at the maximum within 72 hours.
Secondary Correlation between Beck Suicide Intent Scale (BSIS) score and ISI score Correlation between Beck Suicide Intent Scale (BSIS) score and ISI score The Suicide Intent Scale (SIS) wconsists of 15 questions which are scaled from 0-2, which take into account both the logistics of the suicide attempt as well as the intent. The scale has high reliability and validity. Completed suicides ranked higher in the severity of the logistics than attempted suicides (it was impossible to measure intent for the completed suicides), and those with multiple attempts had higher scores than those who only attempted suicide once Baseline (visit inclusion) and at one month ago
Secondary Evolution of ISI score Assess the evolution of sleep disturbances for each group by ISI Score At one month +/- 15 days ant at 3 months +/-3 weeks
Secondary Chronotype classification by MCTQ Exploratory descriptive measures in the 2 groups at the 48 hours after the hospitalization; at the maximum within 72 hours;at 3 months +/-3 weeks
Secondary Pittsburg Sleep Quality Index (PSQI) score PSQI score between the groups PSQI is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score, and takes 5-10 minutes to complete. at the 48 hours after the hospitalization; at the maximum within 72 hours,at 3 months +/-3 weeks
Secondary Childhood Trauma Questionnaire (CTQ) score CTQ score between the groups The Childhood Trauma Questionnaire was developed as a screening tool for histories of abut and neglect. The self-report includes a 28-item test that measures 5 types of maltreatment - emotional, physical, and sexual abuse, and emotional and physical neglect. at the 48 hours after the hospitalization; at the maximum within 72 hours.
Secondary Montréal Cognitive Assessment (MocA) cognitive assessment by Moca test at the 48 hours after the hospitalization; at the maximum within 72 hours.
See also
  Status Clinical Trial Phase
Completed NCT01308151 - Culturally Adapted Cognitive Behavioral Therapy for Prevention of Self Harm N/A
Completed NCT02685943 - A Randomized Trial for Suicidal Patients N/A